Michael F. Mahoney - 12 Sep 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Chairman, President & CEO, Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Sep 2023
Net transactions value
-$4,447,933
Form type
4
Filing time
12 Sep 2023, 17:37:35 UTC
Previous filing
01 Sep 2023
Next filing
10 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $754,454 +57,680 +3.8% $13.08 1,556,602 12 Sep 2023 Direct F1
transaction BSX Common Stock Options Exercise $908,059 +55,675 +3.6% $16.31 1,612,277 12 Sep 2023 Direct F1
transaction BSX Common Stock Sale $6,110,447 -113,355 -7% $53.91 1,498,922 12 Sep 2023 Direct F1, F2
holding BSX Common Stock 176,245 12 Sep 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -55,675 -17% $0.000000 278,376 12 Sep 2023 Common Stock 55,675 $16.31 Direct F1, F3
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -57,680 -33% $0.000000 115,361 12 Sep 2023 Common Stock 57,680 $13.08 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 24, 2023, intended to comply with the prior version of Rule 10b5-1(c).
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.54 to $54.53, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F4 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.